OTC · IMPZY
Healthcare · Medical - Devices
$0.08
Up+$0.00 (+0.00%)
Updated Sep 17, 2026, 8:00 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
IMPZY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning IMPZY.
IMPZY research
Filterable reporting and market headlines.
The latest Smart Investors Daily articles mentioning IMPZY.
No results
No recent SID articles mention IMPZY.
Filters are reflected in the page URL for sharing and back-button support.
1 matching article.
Yahoo · Sep 15, 2026
BORDEAUX, France & BOSTON, September 15, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and in the distribution of advanced medical equipment, today announces its results for the first half of the current financial year, ended June 30, 2026, as approved by the Board of Directors on September 15, 2026.
